Extrathymic malignancies in patients with thymoma

MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database.

ESMO open·2024

A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study.

ESMO open·2024

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Trocar vs. Seldinger small bore pleural drains: does the technique influence the outcomes? A prospective single-centre study.

European review for medical and pharmacological sciences·2023

Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.

Lung cancer (Amsterdam, Netherlands)·2021

Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021